Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure J Rubio-Gracia, BG Demissei, JM Ter Maaten, JG Cleland, CM O'Connor, ... International journal of cardiology 258, 185-191, 2018 | 236 | 2018 |
Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction BG Demissei, RA Hubbard, L Zhang, AM Smith, K Sheline, C McDonald, ... Journal of the American Heart Association 9 (2), e014708, 2020 | 126 | 2020 |
A multimarker multi‐time point‐based risk stratification strategy in acute heart failure: results from the RELAX‐AHF trial BG Demissei, G Cotter, MF Prescott, GM Felker, G Filippatos, ... European journal of heart failure 19 (8), 1001-1010, 2017 | 118 | 2017 |
Optimizing clinical use of biomarkers in high‐risk acute heart failure patients BG Demissei, MAE Valente, JG Cleland, CM O'Connor, M Metra, ... European journal of heart failure 18 (3), 269-280, 2016 | 106 | 2016 |
Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure JM Ter Maaten, D Kremer, BG Demissei, J Struck, A Bergmann, SD Anker, ... European journal of heart failure 21 (6), 732-743, 2019 | 84 | 2019 |
Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review V Narayan, EW Thompson, B Demissei, JE Ho, JL Januzzi Jr, B Ky Journal of the American College of Cardiology 75 (21), 2726-2737, 2020 | 71 | 2020 |
Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer, and lymphoma BG Demissei, G Freedman, SJ Feigenberg, JP Plastaras, A Maity, ... International Journal of Radiation Oncology* Biology* Physics 103 (4), 851-860, 2019 | 69 | 2019 |
A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure A Sharma, BG Demissei, J Tromp, HL Hillege, JG Cleland, CM O'Connor, ... European Journal of Heart Failure 19 (10), 1310-1320, 2017 | 66 | 2017 |
Novel endotypes in heart failure: effects on guideline-directed medical therapy J Tromp, W Ouwerkerk, BG Demissei, SD Anker, JG Cleland, K Dickstein, ... European Heart Journal 39 (48), 4269-4276, 2018 | 59 | 2018 |
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients BG Demissei, JG Cleland, CM O'Connor, M Metra, P Ponikowski, ... International journal of cardiology 204, 164-171, 2016 | 51 | 2016 |
Plasma biomarkers to predict or rule out early post‐discharge events after hospitalization for acute heart failure BG Demissei, D Postmus, JG Cleland, CM O'Connor, M Metra, ... European Journal of Heart Failure 19 (6), 728-738, 2017 | 44 | 2017 |
Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF W Ouwerkerk, AH Zwinderman, LL Ng, B Demissei, HL Hillege, F Zannad, ... Journal of the American College of Cardiology 71 (4), 386-398, 2018 | 40 | 2018 |
Personalized decision making in early stage breast cancer: applying clinical prediction models for anthracycline cardiotoxicity and breast cancer mortality demonstrates … JN Upshaw, R Ruthazer, KD Miller, SK Parsons, JK Erban, AM O’Neill, ... Clinical breast cancer 19 (4), 259-267. e1, 2019 | 28 | 2019 |
Coronary angiography in worsening heart failure: determinants, findings and prognostic implications JP Ferreira, P Rossignol, B Demissei, A Sharma, N Girerd, SD Anker, ... Heart 104 (7), 606-613, 2018 | 28 | 2018 |
Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial J Biegus, B Demissei, D Postmus, G Cotter, BA Davison, GM Felker, ... ESC heart failure 6 (6), 1188-1198, 2019 | 25 | 2019 |
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the … TP Miller, KD Getz, Y Li, BG Demissei, PC Adamson, TA Alonzo, ... The Lancet Haematology 9 (9), e678-e688, 2022 | 18 | 2022 |
Left ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunction BG Demissei, Y Fan, Y Qian, HG Cheng, AM Smith, K Shimamoto, ... European Heart Journal-Cardiovascular Imaging 22 (4), 418-426, 2021 | 18 | 2021 |
Cardiovascular function phenotypes in response to cardiotoxic breast cancer therapy BG Demissei, BS Finkelman, RA Hubbard, AM Smith, HK Narayan, ... Journal of the American College of Cardiology 73 (2), 248-249, 2019 | 15 | 2019 |
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure—post-hoc analysis of the PROTECT trial BG Demissei, D Postmus, LCY Liu, JG Cleland, CM O'Connor, M Metra, ... International journal of cardiology 223, 967-975, 2016 | 15 | 2016 |
Cardiology involvement in patients with breast cancer treated with trastuzumab BG Demissei, S Adusumalli, RA Hubbard, S Denduluri, V Narayan, ... Cardio Oncology 2 (2), 179-189, 2020 | 12 | 2020 |